期刊文献+

Chromatographic behavior of co-eluted plasma compounds and effect on screening of drugs by APCI-LC-MS(/MS):Applications to selected cardiovascular drugs

Chromatographic behavior of co-eluted plasma compounds and effect on screening of drugs by APCI-LC-MS(/MS):Applications to selected cardiovascular drugs
在线阅读 下载PDF
导出
摘要 Chromatographic behavior of co-eluted compounds from un-extracted drug-free plasma samples was studied by LC-MS and LC-MS/MS with positive APCI.Under soft gradient,total ion chromatogram(TIC) consisted of two major peaks separated by a constant lower intensity region.Early peak(0.15-0.4 min) belongs to polar plasma compounds and consisted of smaller mass ions(m/z〈 250);late peak(3.6-4.6 min) belongs to thermally unstable phospholipids and consisted of fragments with mlz〈300.Late peak is more sensitive to variations in chromatographic and MS parameters.Screening of most targeted cardiovascular drugs at levels lower than 50 ng/mL has been possible by LC-MS for drugs with retention factors larger than three.Matrix effects and recovery,at 20 and 200 ng/mL,were evaluated for spiked plasma samples with 15 cardiovascular drugs,by MRM-LC-MS/MS.Average recoveries were above 90%and matrix effects expressed as percent matrix factor(%MF) were above 100%,indicating enhancement character for APCI.Large uncertainties were significant for drugs with smaller masses(m/z〈 250) and retention factors lower than two. Chromatographic behavior of co-eluted compounds from un-extracted drug-free plasma samples was studied by LC-MS and LC-MS/MS with positive APCI.Under soft gradient,total ion chromatogram(TIC) consisted of two major peaks separated by a constant lower intensity region.Early peak(0.15-0.4 min) belongs to polar plasma compounds and consisted of smaller mass ions(m/z〈 250);late peak(3.6-4.6 min) belongs to thermally unstable phospholipids and consisted of fragments with mlz〈300.Late peak is more sensitive to variations in chromatographic and MS parameters.Screening of most targeted cardiovascular drugs at levels lower than 50 ng/mL has been possible by LC-MS for drugs with retention factors larger than three.Matrix effects and recovery,at 20 and 200 ng/mL,were evaluated for spiked plasma samples with 15 cardiovascular drugs,by MRM-LC-MS/MS.Average recoveries were above 90%and matrix effects expressed as percent matrix factor(%MF) were above 100%,indicating enhancement character for APCI.Large uncertainties were significant for drugs with smaller masses(m/z〈 250) and retention factors lower than two.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2014年第6期384-391,共8页 药物分析学报(英文版)
基金 supported by Dean of Scientific Research at Jordan University of Science and Technology(JUST)(No.159/ 2012)
关键词 PLASMA APCI-LC-MS Cardiovascular drugs Matrix effects Recovery Plasma APCI-LC-MS Cardiovascular drugs Matrix effects Recovery
  • 相关文献

参考文献23

  • 1F. Peters, D. Remane, Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology, Anal. Bioanal. Chem. 403 (2012) 2155-2172.
  • 2H. Maurer, Multi-analyte procedure for screening and quantification of drugs in blood, plasma or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology, Clin. Biochem. 38 (2005) 310-318.
  • 3M. Wood, M. Laloup, N. Samyn, et al., Recent Applications of liquid chromatography-mass spectrometry in forensic science, J. Chromatogr. A 1130 (2006) 3-15.
  • 4O. Gonzalez, R. Alonso, N. Feniros, et al., Development of a LC-MS/ MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy, J. Chromatogr. B 879 (2011) 243-252.
  • 5H. Krichherr, W.N. Kiihn-Velten, Quantitative determination of 48 antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level single sample approach, J. Chromatogr. B 843 (2006) 100-113.
  • 6M. Gergov, P. Nokua, E. Vouri, et al., Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry, Forensic Sci. Int. 186 (2009) 36-43.
  • 7V. Viette, D. Guillaerme, R. Mylonas, et al., A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part I), Clin. Biochem. 44 (2011) 32-44.
  • 8A. El-Rjoob, M. Tahtamouni, Y. Tahboub, Simultaneous analysis of fluoxetine, norfluoxetine, citalopram, and haloperidol in plasma by LC-ESI-IT-MS, Chromatographia 71 (2010) 423-430.
  • 9T. Kelly, T.R. Gray, M.A. Huestis, Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium, J. Chromatogr. B 867 (2008) 194-204.
  • 10Food and Drug Administration, Guidelines for Industry. Biomedical Method Validation, US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, USA, 2001.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部